{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:21:08Z","timestamp":1792135268659,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bpobgyn.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T22:39:41Z","timestamp":1620772781000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Human chorionic gonadotrophin assays to monitor GTD"],"prefix":"10.1016","volume":"74","author":[{"given":"Lesley M.","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson W.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Cuthill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2021.05.001_bib1","series-title":"Human chorionic gonadotrophin (hCG)","author":"Cole","year":"2015"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7827-10-24","article-title":"hCG, the wonder of today's science","volume":"10","author":"Cole","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7827-8-102","article-title":"Biological functions of hCG and hCG-related molecules","volume":"8","author":"Cole","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib4","first-page":"1055","article-title":"Exogenous stimulation of corpus luteum formation in the rabbit; influence of extracts of human placenta, decidua, fetus, hydatid mole and corpus luteum on the rabbit gonad","volume":"16","author":"Hirose","year":"1920","journal-title":"J\u00a0Jpn Gynecol Soc"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib5","first-page":"233","article-title":"Studies in history and philosophy of biological","volume":"vol. 47","author":"Olszynko-Gryn","year":"2014","journal-title":"Biomed Sci"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.05.001_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1099-1352(200009\/10)13:5<223::AID-JMR501>3.0.CO;2-L","article-title":"Molecular architecture and biorecognition processes of the cystine knot protein superfamily: Part I. the glycoprotein hormones","volume":"13","author":"Hearn","year":"2000","journal-title":"J\u00a0Mol Recogn"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/369455a0","article-title":"Crystal structure of human chorionic gonadotropin","volume":"369","author":"Lapthorn","year":"1994","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bpobgyn.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/en.2009-1431","volume":"151","author":"Fares","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2011.09.037","article-title":"hCG, five independent molecules","volume":"413","author":"Cole","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.05.001_bib10","first-page":"433","article-title":"Detection of hCG in trophoblastic disease. The USA hCG reference service experience","volume":"47","author":"Cole","year":"2002","journal-title":"J\u00a0Reprod Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/humupd\/dml029","article-title":"The classification, functions and clinical use of different isoforms of HCG","volume":"12","author":"Stenman","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/00365519309086908","article-title":"Standardization of protein immunoprocedures. Choriogonadotropin (CG)","volume":"216","author":"Stenman","year":"1993","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9258(18)33221-6","article-title":"Role of carbohydrate in human chorionic gonadotropin. Effect of deglycosylation on the subunit interaction and on its in\u00a0vitro and in\u00a0vivo biological properties","volume":"258","author":"Kalyan","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7827-7-8","article-title":"New discoveries on the biology and detection of human chorionic gonadotropin","volume":"7","author":"Cole","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbagen.2005.12.022","article-title":"The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists","volume":"1760","author":"Fares","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.placenta.2010.06.005","article-title":"Hyperglycosylated hCG, a review","volume":"31","author":"Cole","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib17","first-page":"150","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/glycob\/cwl034","article-title":"Site-specific glycan analysis of human chorionic gonadotropin b -subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry","volume":"16","author":"Valmu","year":"2006","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.bpobgyn.2021.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mce.2013.12.009","article-title":"Luteinizing hormone and human chorionic gonadotropin: origins of difference","volume":"383","author":"Choi","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"343","key":"10.1016\/j.bpobgyn.2021.05.001_bib21","article-title":"Human chorionic gonadotrophin: new pleiotropic functions for an \u201cold\u201d hormone during pregnancy","volume":"11","author":"Gridelet","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/000456329803500402","article-title":"Analysis of hCG: clinical applications and assay requirements","volume":"35","author":"Sturgeon","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib23","first-page":"e1","article-title":"The management of gestational trophoblastic disease","volume":"128","author":"Tidy","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib24","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1007\/s13277-013-0994-6","article-title":"Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop","volume":"34","author":"Berger","year":"2013","journal-title":"Tumor Biol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2021.05.001_bib25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1373\/clinchem.2009.124578","article-title":"Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin","volume":"55","author":"Sturgeon","year":"2009","journal-title":"Clin Chem"},{"issue":"7\u20138","key":"10.1016\/j.bpobgyn.2021.05.001_bib26","first-page":"285","article-title":"Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors","volume":"55","author":"Harvey","year":"2010","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib27","first-page":"193","article-title":"Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels","volume":"39","author":"Cole","year":"1994","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(00)01324-6","article-title":"False diagnosis and needless therapy of presumed malignantdisease in women with false-positive human chorionicgonadotropin concentrations","volume":"355","author":"Rotmensch","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.05.001_bib29","first-page":"213","article-title":"Molar pregnancy with false negative \u03b2 hcg urine in the emergency department","volume":"12","author":"Hunter","year":"2011","journal-title":"West J Emerg Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.05.001_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jemermed.2013.08.053","article-title":"Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department","volume":"46","author":"Mundangepfupfu","year":"2014","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1258\/acb.2010.090304","article-title":"High-dose hook effect in six automated hCG assays","volume":"47","author":"Al-Mahdili","year":"2010","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"10.1016\/j.bpobgyn.2021.05.001_bib32","first-page":"755","article-title":"Why do immunoassays for tumour markers give differing results?\u2014a view from the UK National External Quality Assessment Schemes","volume":"34","author":"Sturgeon","year":"1996","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"Suppl 2","key":"10.1016\/j.bpobgyn.2021.05.001_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.05.001_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048686","volume":"23","author":"Berger","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9378(72)90553-4","article-title":"A\u00a0radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone","volume":"113","author":"Vaitukaitis","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(72)90087-3","article-title":"A\u00a0radioimmunoassay of TSH, employing a solid phase second antibody and a purified globulin preparation for standardisation of nonspecific protein interactions","volume":"42","author":"Sluiter","year":"1972","journal-title":"Clin. Chem. Acta."},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib37","series-title":". WHO international collaborative study of the proposed 5th [fifth] international standard for chorionic gonadotrophin","author":"Burns","year":"2009"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib38","series-title":"Proposed 6th WHO International Standard for human chorionic gonadotrophin. expert committee on biological standardizatioN geneva","author":"Moore","year":"2020"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib39","series-title":"Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers","author":"Sturgeon","year":"2009"},{"issue":"23\u201324","key":"10.1016\/j.bpobgyn.2021.05.001_bib40","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.cca.2011.08.006","article-title":"Total hCG tests","volume":"412","author":"Cole","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1373\/clinchem.2004.038679","article-title":"Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin","volume":"51","author":"Bristow","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1373\/49.1.144","article-title":"Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites","volume":"49","author":"Birken","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib43","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1080\/00365513.2016.1210334","article-title":"Standardization of tumor markers - priorities identified through external quality assessment","volume":"245","author":"Sturgeon","year":"2016","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/meth.2000.0973","article-title":"Antibodies and immunoassays","volume":"21","author":"Madersbacher","year":"2000","journal-title":"Methods"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2011.10.029","article-title":"Hyperglycosylated hCG, hCG\u03b2 and Hyperglycosylated hCG\u03b2: interchangeable cancer promoters","volume":"349","author":"Cole","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.05.001_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228507","article-title":"Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis","volume":"15","author":"Ibeto","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/ENDO:10:2:137","article-title":"Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinomahCG","volume":"10","author":"Birken","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.bpobgyn.2021.05.001_bib48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clinbiochem.2004.05.008","article-title":"Human chorionic gonadotropin in cancer","volume":"37","author":"Stenman","year":"2004","journal-title":"Clin Biochem"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693421000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693421000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:13:15Z","timestamp":1761498795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693421000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":48,"alternative-id":["S1521693421000687"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.05.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human chorionic gonadotrophin assays to monitor GTD","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}